XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED INVESTMENT PRODUCTS (Tables)
 3 Months Ended
Mar. 31, 2025
Consolidated Sponsored Investment Portfolios [Abstract]  
Schedule of Net Assets of Consolidated T. Rowe Price Investment Portfolios
The following table details the net assets of the consolidated investment products:
3/31/202512/31/2024
(in millions)
Voting
interest entities
Variable interest entities
Total
Voting
interest entities
Variable interest entities
Total
Cash and cash equivalents(1)
$0.4 $50.4 $50.8 $7.2 $55.9 $63.1 
Investments(2)
92.9 1,628.4 1,721.3 470.8 1,465.4 1,936.2 
Other assets0.5 21.8 22.3 10.4 34.3 44.7 
Total assets93.8 1,700.6 1,794.4 488.4 1,555.6 2,044.0 
Liabilities1.2 40.8 42.0 15.9 46.2 62.1 
Net assets$92.6 $1,659.8 $1,752.4 $472.5 $1,509.4 $1,981.9 
Attributable to T. Rowe Price Group, Inc.$73.6 $701.6 $775.2 $348.5 $689.4 $1,037.9 
Attributable to redeemable non-controlling interests19.0 958.2 977.2 124.0 820.0 944.0 
$92.6 $1,659.8 $1,752.4 $472.5 $1,509.4 $1,981.9 
(1) Cash and cash equivalents includes $0.2 million at March 31, 2025, and $4.9 million at December 31, 2024, of investments in T. Rowe Price money market mutual funds.
(2) Investments include $9.6 million at March 31, 2025, and $9.3 million at December 31, 2024 of other T. Rowe Price investment products.
Schedule of Operating Results of Consolidated T. Rowe Price Investment Portfolios
The operating results of the consolidated investment products for the three months ended March 31, 2025 and 2024, are reflected in our unaudited consolidated statements of income as follows:

Three months ended
3/31/20253/31/2024
(in millions)Voting
interest entities		Variable interest entitiesTotalVoting
interest entities		Variable interest entitiesTotal
Operating expenses reflected in net operating income$(0.2)$(2.3)$(2.5)$(0.8)$(1.5)$(2.3)
Net investment income (loss) reflected in non-operating income (loss)15.1 16.8 31.9 33.4 38.9 72.3 
Impact on income before taxes$14.9 $14.5 $29.4 $32.6 $37.4 $70.0 
Net income (loss) attributable to T. Rowe Price Group, Inc.$10.2 $4.6 $14.8 $25.8 $24.6 $50.4 
Net income (loss) attributable to redeemable non-controlling interests4.7 9.9 14.6 6.8 12.8 19.6 
$14.9 $14.5 $29.4 $32.6 $37.4 $70.0 
Schedule of Cash flows of Consolidated T. Rowe Price Investment Portfolios
The table below details the impact of these consolidated investment products on the individual lines of our unaudited consolidated statements of cash flows for the three months ended March 31, 2025 and 2024.
Three months ended
3/31/20253/31/2024
(in millions)
Voting
interest entities
Variable interest entities
Total
Voting
interest entities
Variable interest entities
Total
Net cash provided by (used in) operating activities$(79.6)$(57.5)$(137.1)$(61.8)$(33.9)$(95.7)
Net cash provided by (used in) investing activities0.7 3.0 3.7 — (0.1)(0.1)
Net cash provided by (used in) financing activities72.1 48.1 120.2 72.7 34.1 106.8 
Effect of exchange rate changes on cash and cash equivalents of consolidated investment products— 0.9 0.9 — (0.8)(0.8)
Net change in cash and cash equivalents during period
(6.8)(5.5)(12.3)10.9 (0.7)10.2 
Cash and cash equivalents at beginning of year
7.2 55.9 63.1 25.7 51.5 77.2 
Cash and cash equivalents at end of period
$0.4 $50.4 $50.8 $36.6 $50.8 $87.4 
Schedule of Fair Values of Investments Held by Consolidated T. Rowe Price Investment Portfolios The following table summarizes the investment holdings held by our consolidated investment products using fair value measurements determined based on the differing levels of inputs.
3/31/202512/31/2024
(in millions)
Level 1
Level 2
Level 1
Level 2
Assets
  Cash equivalents$0.2 $— $6.3 $— 
Equity securities396.6 205.4 452.3 285.4 
Fixed income securities— 1,090.5 — 1,173.5 
Other investments1.2 27.6 1.6 23.4 
$398.0 $1,323.5 $460.2 $1,482.3 
Liabilities$(0.6)$(11.3)$(1.7)$(14.5)